Low vaccination rate for flu vaccines in diabetic patients

"The vaccination rate for flu vaccines in diabetic patients in Austria is unfortunately particularly low," says study leader Thomas Dorner from the Institute of Social Medicine (Public Health Centre) at the Medical University of Vienna. An "unsettling gender difference" has also been noted, with men in this case taking the lead: 39 per cent of male diabetics are vaccinated against flu, whereas only 30 per cent of female diabetics are.

This also means that the likelihood of being vaccinated against flu is 61 per cent higher for male diabetics than for non-diabetics, whereas for women there is no difference between the level of vaccination between people with or without diabetes. Says Dorner: "The aggregated data invites the conclusion that the vaccination rate among diabetic patients in Austria needs to be considerably stepped up and that there is a gender gap here which needs to be closed."

For diabetics, who are at higher risk of infections anyway, the consequences of flu are much more serious than for non-diabetics, explains Alexandra Kautzky-Willer, Professor of Gender Medicine at the MedUni Vienna. "The risk of developing heart problems is significantly higher."

http://www.meduniwien.ac.at

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment
Post

Sign in to keep reading

We're committed to providing free access to quality science. By registering and providing insight into your preferences you're joining a community of over 1m science interested individuals and help us to provide you with insightful content whilst keeping our service free.

or

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

You might also like...
COVID-19, RSV, and flu vaccines remain safe and effective